Beat The Denominator

Consider Hims & Hers (HIMS) as the premier sector leader for high-growth exposure to the telehealth megatrend, driven by its dominant scale and projected revenue growth of 34% to 40%.

Alternatively, view LifeMD (LFMD) as a high-risk, deep-value turnaround play or speculative acquisition target given its dirt-cheap price-to-sales multiple of 0.6 and built-out insurance-reimbursement infrastructure.

Investors in LFMD should closely monitor management's ability to achieve positive EBITDA by the end of the year without causing further deceleration from its modest 8% projected 2026 revenue growth.

Evaluate LFMD's unique insurance-accepting model as a potential defensive moat against pure-play competitors, especially regarding future Medicare tailwinds for GLP-1 medications.

Track upcoming guidance updates for HIMS following recent acquisitions like Eucalyptus to ensure the company continues outpacing smaller telehealth peers.

Capitalize on the recent 13% drop in Oscar Health (OSCR) by treating it as a compelling long-term hold, given its massive revenue beats and dirt-cheap valuation. Ignore Wall Street's overreaction to standard medical loss ratio cycles and view OSCR as fundamentally disconnected from its short-term price sell-off. Accumulate shares of Celsius Holdings (CELH) following its recent 17% post-earnings drop, which was driven by temporary inventory noise rather than core business deterioration. Leverage CELH's deep value status, boasting a stellar Rule of 40 score of 61 and strong market share gains against legacy competitors Red Bull and Monster. Use the current summer market illiquidity to buy both OSCR and CELH at steep discounts for significant multi-quarter upside.

Buy Zeta Global Holdings Corp. (ZETA) as a compelling medium-term growth play, supported by its proprietary global tracking moat, enterprise-level AI partnerships, and an attractive valuation relative to its rapid expansion. Accumulate TransMedics Group, Inc. (TMDX) for long-term turnaround potential as it targets $2 billion in revenue by 2032, though investors should remain cautious of near-term Medicare reimbursement risks. Position in SoFi Technologies, Inc. (SOFI) as a leveraged trade on lower interest rates, where a drop in borrowing costs could trigger a major valuation re-rating. Monitor digital credit instruments like STRC and MicroStrategy (MSTR) for recovery plays as Bitcoin sentiment stabilizes and Treasury yields decline.

Consider building a long-term position in Zillow Group (ZG), which is currently trading down roughly 65% to 66% from its peak due to macroeconomic interest rate pressures rather than weak business fundamentals.

Exercise caution and wait for upcoming earnings results before making a heavy investment, as summer mortgage rates near 7% may have negatively impacted recent home sales.

Monitor macroeconomic indicators closely and look for 30-year mortgage rates to decline toward 4% before expecting a major market turnaround.

As the housing market eventually normalizes, successful execution by Zillow Group (ZG) could drive significant revenue acceleration and potential 3x to 5x stock appreciation over a longer investment horizon.

Maintain similar patience with deeply discounted real estate plays like REACs, ensuring you tie any new trades strictly to an eventual drop in interest rates and improved housing market liquidity.

Investors should expect continued volatility and a "slow bleed" in Bitcoin (BTC) and related assets while the current bear market persists.

Long-term investors can look past short-term fear and minor news events, as historical precedent suggests that bear markets are temporary.

Watch for a recovery in Bitcoin (BTC) back toward the $80,000 price target, which serves as the primary catalyst for the broader crypto ecosystem.

MicroStrategy (MSTR) operates as a leveraged proxy for Bitcoin (BTC) and will only see meaningful stock recovery once the underlying cryptocurrency rebounds.

Ignore minor corporate noise like small balance sheet adjustments or tax-loss selling, focusing instead on the macro recovery timeline expected within the next couple of months.

Accumulate shares of Meta Platforms (META) as it currently trades as the cheapest Magnificent 7 stock, sitting roughly 20% cheaper than NVIDIA (NVDA).

Take advantage of NVIDIA’s favorable valuation near the $200 price level, as its fabless business model allows for rapid scaling during the ongoing AI boom.

Target Micron Technology (MU) around the $820 level as a top hardware pick, supported by an ultra-low P/E ratio of 4.5 to 5 and a shift away from pure cyclicality.

Invest in Nebius (NBIS) while it trades under the $200 threshold, capitalizing on its temporary valuation dip and multi-billion-dollar enterprise contracts.

Avoid overvalued AI hardware plays like Advanced Micro Devices (AMD) and Broadcom (AVGO) until their valuation multiples drop to align more closely with industry peers.

Accumulate Bitcoin (BTC) near the $63,000 support level while monitoring for geopolitical de-escalation in the Middle East as a catalyst for a relief rally.

Watch for STRC to break the psychological $90 resistance level—currently trading at $89.50—to signal a recovery toward 100 before the asset resumes aggressive buying.

Keep a close eye on the 30-year Treasury yields, as high borrowing costs will continue to pressure digital credit instruments like STRC.

Consider utilizing regulated ETF wrappers like iBit or equity proxies like MicroStrategy (MSTR) to gain exposure while avoiding self-custody risks associated with hardware wallets.

Expect near-term stagnation for MicroStrategy (MSTR) and Bitcoin (BTC) near $64,700 as management halts token purchases to fortify cash reserves by $500 million. Because MSTR stock currently correlates 1:1 with the iShares Bitcoin Trust ETF (IBIT) due to common stock dilution, avoid aggressive buying until broader macroeconomic trends improve. Watch for a recovery in the digital credit "Stretch" instrument targeting $100, backed by an available $975 million buyback authorization. With macro headwinds like the 10-year Treasury yield near 4.7% creating fierce competition for credit, wait for the Federal Reserve to signal interest rate cuts before entering new positions. Patient investors should monitor cooling inflation and easing geopolitical tensions as the primary catalysts for the next sustainable breakout in risk assets.

Capitalize on the recent macro-driven sell-off in Nebius (NEBIUS), which is down 50% from its June peak despite secure enterprise contracts worth billions with Microsoft and Meta. View the recent drop in Hims & Hers Health (HIMS) as a temporary buying opportunity, because the pending FTC lawsuit will likely take until 2030 or 2031 to resolve while its GLP-1 and international catalysts ramp up. Accumulate shares of SoFi Technologies (SOFI) during market-wide pullbacks, as its consistent earnings beats and a strong Rule of 40 score of 67 indicate the current flat stock price is disconnected from its robust fundamentals. Use these broader market sell-offs to build positions in these discounted growth names, keeping in mind that near-term volatility and macro fears may persist. Ensure you align your entry points with a medium-to-long-term investment horizon to ride out any lingering headline risks and sentiment-driven dips.

Accumulate shares of Nebius (NBIS) around the $1.70 pullback level to capitalize on its massive $40 billion AI infrastructure backlog and discounted neocloud valuation. Buy Micron Technology (MU) while it trades at a cheap forward P/E of 4x to 5x earnings, as the market misprices its transition into a structural AI and robotics memory supplier. Purchase NVIDIA (NVDA) below $200 to capture an expected 62% revenue growth rate backed by its dominant CUDA platform and AI market leadership. Take advantage of the recent sell-off in Hims & Hers Health (HIMS) within the $27–$29 range to secure a high-growth, recession-resistant healthcare subscription model with over 2 million recurring subscribers. Finally, buy Meta Platforms (META) as the cheapest Magnificent Seven stock, though investors should exercise caution around upcoming earnings due to potential volatility over AI spending.

Expect near-term weakness in MSTR common stock while the company continues issuing shares to support its digital credit initiatives. Watch for Bitcoin to break out from its current $65,000 stagnation range toward the high $70,000s or low $80,000s before entering a sustained recovery trade. Monitor preferred stock STRC for larger buybacks exceeding the initial $25 million deployment if prices drop further. Factor in broader macroeconomic headwinds, specifically the 10-year Treasury yield touching 4.70%, when evaluating fixed-income and preferred products. Exercise patience through the summer months, anticipating a return of market momentum and higher activity levels by September.

Capitalize on the recent unwarranted 7% sell-off in Google (GOOG) and the 15% drop in Tesla (TSLA), as both fundamentally sound tech giants were oversold during broader market liquidity panics. Exercise caution with the Artificial Intelligence Sector (NVIDIA, Micron, AMD, Amazon) due to extreme concentration risk, as a cooling in AI momentum could disproportionately drag down the Nasdaq. Reevaluate fixed-income exposure immediately, as the iShares 20+ Year Treasury Bond ETF (TLT) sits near historical lows and fails to provide traditional portfolio stability. Consider accumulating Bitcoin (BTC) for resilient portfolio protection, targeting a major psychological breakout toward $100,000 as it successfully decouples from broader equity bloodbaths. Finally, favor direct Bitcoin holdings over Strategy to avoid the short-term common stock dilution caused by the company's aggressive At-The-Market equity offerings.

• Micron Technology ($MU) is a high-conviction buy after the sell-off to the low $800s, with a quick potential to reclaim $1,000—it’s the cheapest AI stock given its explosive growth.
• Nebius ($NBIS), a leading AI cloud provider, is very attractive below $200; use limit orders to buy during the wild swings common to this name.
• Super Micro Computer ($SMCI) surged on chatter of a 5x revenue jump next quarter, presenting a near-term catalyst at a dirt-cheap valuation.
• NVIDIA ($NVDA) offers the best risk/reward among chip plays and should be accumulated on any macro-driven dips.
• Keep some cash ready, as market volatility will likely create repeated entry points for these high-conviction AI investments.

Investors should consider MicroStrategy (MSTR) a "hold" as the company builds a $3.2 billion cash reserve to insulate itself against market volatility. This massive liquidity cushion is specifically designed to guarantee dividend payments for STRC (preferred stock) for the next 22 months, making the preferred shares a safer play for income-focused investors. While the balance sheet is strengthening, MSTR remains highly correlated to Bitcoin, requiring a recovery toward $80,000 for a significant price breakout. Monitor STRC as the company works to restore these shares to par value, which would signal renewed institutional confidence. For now, the most actionable move is to wait for Bitcoin price stabilization before increasing exposure to the common equity.

Bitcoin (BTC) has shown significant resilience against geopolitical turmoil, making it a high-conviction hold as it targets a breakout toward the $70,000 - $75,000 range following the summer months. Investors should view MicroStrategy (MSTR) as the primary institutional vehicle for this move, benefiting from massive liquidity and trading volume comparable to major ETFs like the QQQ. While MSTR is currently consolidating near its net asset value, a significant rally in BTC is the expected catalyst to drive the stock toward its valuation goal of $100. For those in high-tax jurisdictions like California or New York, utilizing credit instruments with a Return of Capital (ROC) structure allows for tax-deferred income and long-term wealth preservation. This strategy is particularly effective for retirees or estate planning, as it enables drawing income without immediate tax hits while potentially providing heirs with a stepped-up cost basis.

Micron Technology (MU) presents a high-conviction value opportunity, currently trading at an extreme discount with an implied forward P/E of just 4x despite its critical role in the AI memory bottleneck. While NVIDIA (NVDA) and Tesla (TSLA) face short-term stagnation due to macro fears, they remain essential long-term holds as their technological advancements continue to outpace their stock prices. For those seeking a hedge against current market volatility, the Hyperliquid (HYPE) token offers a deflationary model where 99% of platform fees are used to burn supply. Bitcoin (BTC) has emerged as a surprising "stable" asset and safe haven for investors looking to escape the irrationality and high volatility of growth tech stocks. Given the current "summer slump" and geopolitical uncertainty, investors should avoid using margin and consider waiting until after the midterm elections to deploy significant new capital.

Micron Technology (MU) is currently in a "deep buy zone" at $85.50, offering a massive valuation disconnect with a forward P/E in the low 4s. Investors should favor NVIDIA (NVDA) over Apple (AAPL) or AMD, as it remains the cheapest "Magnificent 7" stock when adjusted for its dominant AI hardware growth. Nebius (NBIS) presents a high-conviction entry point at $1.77, a price level described as a "gift" following a nonsensical 30% valuation collapse. Look for value in Bitcoin miners and Samara Asset Group (SMR), which are undervalued plays on the AI build-out due to their rare access to energy infrastructure. Given current macro volatility, these positions should be approached with a long-term horizon extending toward 2030 rather than seeking short-term gains.

Enlivex Therapeutics (ENLV) presents a massive arbitrage opportunity as it trades at a Modified Net Asset Value (mNAV) of 0.17, allowing investors to buy its crypto treasury at an 83% discount. The company holds 79.5 billion RAIN tokens worth approximately $1.13 billion, yet its market cap remains under $200 million, creating a significant lag behind the underlying asset's recent price appreciation. By purchasing ENLV at these levels, investors effectively acquire a Phase 2 biotech pipeline for free, though it should be treated as a high-risk "sleeper" position due to token volatility. The underlying RAIN token benefits from a deflationary 50% buyback and burn mechanism driven by its Layer 3 prediction market protocol, though high supply concentration remains a key risk. Investors should monitor the narrowing valuation gap between the stock price and the RAIN treasury holdings as the market "discovers" this Digital Asset Treasury (DAT) play.

Investors should view the next 60 days as a final accumulation window for Bitcoin (BTC), as the current bear cycle is estimated to end within two months. For higher potential returns, MicroStrategy (MSTR) serves as a leveraged play on BTC and is currently trading at an attractive valuation gap relative to its net asset value. Income-focused investors should consider Strateos (STRC), which offers high dividend security backed by 20 months of USD reserves and a clear path toward returning to par value. Monitor Federal Reserve interest rate signals closely, as lower inflation data remains the primary catalyst for BTC to trend upward toward its recent $65,000 highs. Additionally, watch for the "Bitcoin Treasury" sector to mature as institutional adoption within the banking system climbs toward a 50% integration target.

Investors should prioritize Micron Technology (MU) as a top AI play, targeting an entry point below $900 to capitalize on its transition to long-term contracts and a low forward P/E of 5. Micron is particularly attractive because high-bandwidth memory has become a critical AI bottleneck with no significant new supply expected until 2028. For a high-growth infrastructure play, look to buy Nebius Group (NBIS) if the price dips below $200, benefiting from its priority NVIDIA GPU access and its undervalued 28% stake in ClickHouse. While NVIDIA (NVDA) remains the industry benchmark, its short-term upside may be limited by macro headwinds, making it a secondary focus compared to memory providers. Use recurring "monthly dumps" triggered by oil prices rising above $80 to aggressively accumulate these high-conviction AI names at a discount.